COVID-19 presenting with diarrhea in a heart transplant patient.

التفاصيل البيبلوغرافية
العنوان: COVID-19 presenting with diarrhea in a heart transplant patient.
المؤلفون: Işık ME; Department of Infectious Diseases and Clinical Microbiology, Koşuyolu Yüksek Ihtisas Training and Research Hospital, Istanbul, Turkey., Günay D; Department of Cardiovascular Surgery, Koşuyolu Yüksek Ihtisas Training and Research Hospital, Istanbul, Turkey., Aksüt M; Department of Cardiovascular Surgery, Koşuyolu Yüksek Ihtisas Training and Research Hospital, Istanbul, Turkey., Menekşe Ş; Department of Infectious Diseases and Clinical Microbiology, Koşuyolu Yüksek Ihtisas Training and Research Hospital, Istanbul, Turkey., Uygun-Kızmaz Y; Department of Infectious Diseases and Clinical Microbiology, Koşuyolu Yüksek Ihtisas Training and Research Hospital, Istanbul, Turkey., Kırali MK; Department of Cardiovascular Surgery, Koşuyolu Yüksek Ihtisas Training and Research Hospital, Istanbul, Turkey.
المصدر: Turk gogus kalp damar cerrahisi dergisi [Turk Gogus Kalp Damar Cerrahisi Derg] 2021 Jan 13; Vol. 29 (1), pp. 119-121. Date of Electronic Publication: 2021 Jan 13 (Print Publication: 2021).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Bayçınar Medical Publishing Country of Publication: Turkey NLM ID: 100887967 Publication Model: eCollection Cited Medium: Print ISSN: 1301-5680 (Print) Linking ISSN: 13015680 NLM ISO Abbreviation: Turk Gogus Kalp Damar Cerrahisi Derg Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: [İstanbul, Turkey] : Bayçınar Medical Publishing
Original Publication: İstanbul : Türk Kalp Damar Cerrahisi Derneǧi
مستخلص: A 55-year-old man who underwent bicaval orthotopic heart transplantation nine months earlier presented with complaints of diarrhea and oliguria. Laboratory findings showed pancytopenia and an elevated creatinine level. Cyclosporine and mycophenolate mofetil were discontinued, and the patient received only everolimus. As he was immunosuppressed and had atypical symptoms during the COVID-19 pandemic, reverse transcriptase-polymerase chain reaction testing was performed, which yielded a positive result. Treatment with hydroxychloroquine and favipiravir were initiated. Although the patient suffered from acute renal failure, his condition showed an improvement after hydration plus a five-day antiviral treatment and, then, treatment was stopped. His COVID-19 test was negative after 10 days of follow-up and treatment, and he was discharged with cyclosporin and mycophenolate mofetil.
Competing Interests: Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
(Copyright © 2021, Turkish Society of Cardiovascular Surgery.)
References: Clin Gastroenterol Hepatol. 2020 Jul;18(8):1753-1759.e2. (PMID: 32311512)
Am J Transplant. 2020 Jul;20(7):1849-1858. (PMID: 32301155)
N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
JAMA Cardiol. 2020 May 13;:. (PMID: 32402056)
J Heart Lung Transplant. 2020 May;39(5):496-497. (PMID: 32362394)
Gastroenterology. 2020 Sep;159(3):1161-1163.e2. (PMID: 32422209)
J Thromb Haemost. 2020 May;18(5):1094-1099. (PMID: 32220112)
Am J Transplant. 2020 Oct;20(10):2916-2922. (PMID: 32378314)
Am J Transplant. 2020 Jul;20(7):1800-1808. (PMID: 32330343)
فهرسة مساهمة: Keywords: COVID-19; diarrhea; favipiravir; hydroxychloroquine
تواريخ الأحداث: Date Created: 20210326 Latest Revision: 20210327
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC7970087
DOI: 10.5606/tgkdc.dergisi.2021.20420
PMID: 33768991
قاعدة البيانات: MEDLINE
الوصف
تدمد:1301-5680
DOI:10.5606/tgkdc.dergisi.2021.20420